The cluster is too small and one-sided to signal a directional thesis. The large trim by Assenagon outweighs the small adds. Monitor next 13F for whether the trimming continues or reverses.
CLDX drugs
CLDX drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 3 $29.71entry
- T+1 · 13d ago +0.74%α −0.91% · $29.93
- T+5 · 7d ago +3.16%α +3.75% · $30.65
- T+9 · todayOpen
- T+20 · in 15d Pending
- T+60 · in 3mo Pending
How similar events traded
Executive Summary
Three small asset managers added to their CLDX positions in Q3 2026, while one larger holder trimmed significantly. The net institutional activity is modest and mixed, with total buying of $665K against a single $14.9M trim, suggesting no strong shared thesis.
Key Financial Metrics
Institutional Positions
Net institutional flow: -$14.2M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Strs Ohio | ADD | +71.9% | $713.0K | $237.0K |
| Alps Advisors | ADD | +31.4% | $3.4M | $427.0K |
| Farther Finance Advisors | ADD | +32.9% | $9.0K | $1.0K |
▼ Sellers (1)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Assenagon Asset Management | TRIM | -43.6% | $29.3M | -$14.9M |
Key Facts
- 3 small asset managers added CLDX positions totaling $665K in Q3 2026
- 1 larger holder (Assenagon) trimmed 43.6% of its position, reducing value by $14.9M
- Net institutional flow was negative $14.2M (buying minus selling)
- No open-market insider buying was detected in the same window
- All moves were by asset managers, no activist or high-conviction funds involved
Financial Impact
Total buying of $665K by three small funds, offset by a single $14.9M trim from Assenagon. Net institutional outflow of approximately $14.2M.
Risk Factors
- 13F data is 45+ days stale; positions may have changed since quarter-end
- Small adds by three minor funds carry limited signal
- No insider buying to corroborate institutional conviction
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-CLDX-2026-Q3 |
Track record
21 reports on CLDX
4 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +19.96% at T+20 after the Jun 14, 2026 report. 4 of 8 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $28.97 settles Feb 12
- Nov 5, 202611d ago S-3ASR Neutral 3/10 Entry $29.87 settles Feb 4
- Nov 5, 202611d ago 8-K Neutral 5/10 Entry $29.87 settles Feb 4
- Nov 3, 202613d ago Institutional Cluster Neutral 2/10 Viewing Entry $29.71 settles Feb 1
- Oct 7, 20265w ago SC 13G/A Neutral 3/10 Entry $30.43 settles Jan 4
- Sep 22, 20267w ago Institutional Cluster Bullish 4/10 Entry $33.51 settles Dec 16
- Sep 22, 20267w ago 8-K Bullish 7/10 Entry $33.51 settles Dec 16
- Sep 22, 20267w ago Press Release Bullish 7/10 Entry $33.51 settles Dec 16
- Jun 14, 202622w ago Press Release Bearish 6/10 Entry $32.12 to $38.10 ▼ −18.62% −18.22% vs SPY
- Jun 14, 202622w ago Press Release Bullish 7/10 Entry $32.12 to $38.10 ▲ +18.62% +18.22% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers